Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected6M Return
Partial Period · Feb 26, 2026 — Mar 24, 2026
Four symbols is the limit; remove one to add another.
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | MRNA | PFE | BACK |
|---|---|---|---|---|
| Return | ||||
| Last Price | — | — | 28.55 | — |
| Daily Change | — | — | − 0.90% | — |
| Period ReturnPast 6 Months | — | + 174.39% | + 5.28% | 0.00%Feb 26, 2026 — Mar 24, 2026 |
| Valuation | ||||
| Market Cap | $4.50 B | $57.9 B | $163 B | $1.89 K |
| P/E Ratio | — | — | 37.79 | — |
| Dividend Yield | — | — | 5.38% | — |
| Net MarginTrailing 12M | — | 141.4% | 6.8% | 23,232.4% |
| Risk | ||||
| Beta | — | 1.22 | 0.28 | -1.12 |
| 52-Week Range | — | 22.28 — $176.66 | 23.58 — $29.21 | 0.00 — $0.21 |
| Company | ||||
| Sector | — | Health Care | Health Care | — |
| Industry | Biotechnology | Biotechnology | Pharmaceuticals | Biotechnology |
Company
- AKROBiotechnology
- MRNAHealth Care · Biotechnology
- PFEHealth Care · Pharmaceuticals
- BACKBiotechnology
Metrics could not be loaded for AKRO: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 20:00
To Understand This